CD151 promotes proliferation and migration of PC3 cells via the formation of CD151-integrin α3/α6 complex

Abstract

Over-expression of CD151 was found to be associated with metastasis and poor prognosis of prostatic carcinoma. This study was designed to examine the mechanism by which CD151 promotes the proliferation and migration of prostatic cancer cells. The pAAV-CD151, pAAV-GFP and pAAV-CD151-AAA mutant plasmids were constructed and used to transiently transfect PC3 cells (a prostatic carcinoma 3 cell line) by the mediation of Fugene HD. Then, the cells were assigned to control group, pAAV-GFP group, pAAV-CD151 group, and pAAV-CD151-AAA group respectively. Cell proliferation was evaluated by using the 3-[4,5-dimet-hylthiazol-2-yl]-2,5, diphenyltetrazolium bromide (MTT) method. Cell migration assay was performed by using Boyden chambers. The formation of CD151-integrin α3/α6 complex was determined by the method of co-immunoprecipitation. The protein expression levels of CD151 and extracellular signal-regulated kinase (ERK) were measured by Western blotting. The results showed that transfection of pAAV-CD151 or pAAV-CD151-AAA mutant increased the expression of CD151 protein in PC3 cells. Co-immunoprecipitation showed that more CD151-integrin α3/α6 complex was formed in the pAAV-CD151 group than in the control group, the pAAV-GFP group and the pAAV-CD151-AAA mutant group. Furthermore, the proliferative and migrating capacity of PC3 cells was substantially increased in the pAAV-CD151 group but inhibited in the pAAV-CD151-AAA mutant group. CD151 transfection increased the expression of phospho-ERK. Taken together, it was concluded that CD151 promotes the proliferation and migration of PC3 cells through the formation of CD151-integrin complex and the activation of phosphorylated ERK.

Keywords

CD151 / integrin / ERK / CD151-AAA

References

[1] AngJ., LijovicM., AshmanL.K., et al.. CD 151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a new prognostic indicator?. Cancer Epidemiol Biomarkers Prev, 2004, 13(1): 1717-1721

[2] AngJ., FangB.L., AshmanL.K., et al.. The migration and invasion of human prostate cancer cell lines involves CD151 expression. Oncol Rep, 2010, 24(6): 1593-1597

[3] ZhangX.A., BontragerA.L., HemlerM.E.. Transmembrane 4 superfamily proteins associate with activated protein kinase C (PKC) and link PKC to specific β1 integrins. J Biol Chem, 2001, 276(27): 25005-25013

[4] WeiQ., LiuZ., FeiY., et al.. Adeno-associated viral vector mediated and cardiac-specific delivery of CD151 gene in ischemic rat hearts. J Huazhong Univ Sci Technolog Med Sci, 2011, 31(1): 46-51

[5] LiuL., HeB., LiuW.M., et al.. Tetraspanin CD151 promotes cell migration by regulating integrin trafficking. J Biol Chem, 2007, 282(43): 31631-31642

[6] KazarovA.R., YangX., StippC.S., et al.. An extracellular site on tetraspanin CD151 determines alpha 3 and alpha 6 integrin-dependent cellular morphology. J Cell Biol, 2002, 158: 1299-1309

[7] BerditchevskiF., GilbertE., GriffithsM.R.. Analysis of the CD151-alpha3beta1 integrin and CD151-tetraspanin interactions by mutagenesis. J Biol Chem, 2001, 276(44): 41165-41174

[8] KazarovA.R., YangX., StippC.S., et al.. An extracellular site on tetraspanin CD151 determines α3β1 and α6β1 integrin-dependent cellular morphology. J cell Bio, 2002, 158(7): 1299-1309

[9] ZuoH.J., LinJ.Y., LiuZ.Y., et al.. Activation of the ERK signaling pathway is involved in CD151-induced angiogenic effects on the formation of CD151-integrin complexes. Acta Pharmacol Sin, 2010, 31: 805-812

[10] LiuW.F., ZuoH.J., ChaiB.L., et al.. Role of tetraspanin CD151-α3/α6 integrin complex: Implication in angiogenesis CD151-integrin complex in angiogenesis. Int J Biochem Cell Biol, 2011, 43(4): 642-650

[11] ZhangJ., LuoW., LiuZ., et al.. Effects of transfection of ICAP-1α and its mutants on adhesion and migration of 2H-11 cells. J Huazhong Univ Sci Technolog Med Sci, 2010, 30(5): 569-574

[12] FitterS., TetazT.J., BerndtM.C., et al.. Molecular cloning of cDNA encoding a novel platelet-endothelial cell tetraspan antigen, PETA-3. Blood, 1995, 86(4): 1348-1355

[13] ZhangX.A., KazarovA.R., YangX.. Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis. Mol Biol Cell, 2002, 13(1): 1-11

[14] SchmelzM., CressA.E., ScottK.M., et al.. Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia, 2002, 4(3): 243-254

[15] VossM.A., GordonN., MaloneyS., et al.. Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer. Br J Cancer, 2011, 104(10): 1611-1618

[16] TokuharaT., HasegawaH., HattoriN., et al.. Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin Cancer Res, 2001, 7(12): 4109-4114

[17] HashidaH., TakabayashiA., TokuharaT., et al.. Clinical significance of transmembrane 4 superfamily in colon cancer. Br J Cancer, 2003, 89(1): 158-167

[18] TestaJ.E., BrooksP.C., LinJ.M., et al.. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res, 1999, 59(15): 3812-3820

[19] KohnoM., HasegawaH., MiyakeM., et al.. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer, 2002, 97(3): 336-343

[20] ZuoH., LiuZ., LiuX., et al.. CD151 gene delivery after myocardial infarction promotes functional neovasculariz ation and activates FAK signaling. Mol Med, 2009, 15: 307-315

[21] NakabayashiH., ShimizuK.. HA1077, a Rho kinase inhibitor, suppresses glioma-induced angiogenesis by targeting the Rho-ROCK and the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK) signal pathways. Cancer Sci, 2011, 102(2): 393-399

[22] GollobJ.A., WilhelmS., CarterC., et al.. Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol, 2006, 33(4): 392-406

[23] KimL.C., SongL., HauraE.B.. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol, 2009, 6(10): 587-595